Private
Roche and Atea Pharmaceuticals, Inc. are now collaborating on the development, manufacture, and distribution of AT-527, an Atea-created investigational oral antiviral for use on COVID-19.
The drug, which is currently in phase two clinical trials for hospitalized patients with moderate COVID-19,... Read More »
While the pursuit of treatments and vaccines for COVID-19 is ongoing, the U.S. Food and Drug Administration (FDA) announced a major milestone last week with the approval of the first treatment for the deadly disease: Gilead Sciences Inc.’s Veklury, also known as remdesivir.
The approval is... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) has expanded the manufacturing network for its COVID-19 vaccine portfolio.
The nonprofit foundation, which finances independent research projects to develop vaccines against emerging infectious diseases, has signed vaccine manufacturing... Read More »
The threat detection and security screening technologies firm Smiths Detection is touting the benefits of integrating its CTX 9800 DSi explosive detection system with a tote-based Baggage Handling System (BHS).
“We have gained expertise by working with a broad range of baggage handling system... Read More »
National Geospatial-Intelligence Agency (NGA) officials said a geospatial technology lab slated for launch at the T-REX innovation center in St. Louis, Missouri, would advance regional NGA, industry, and academia efforts.
“We will deliver trusted GEOINT with the speed, accuracy, and precision... Read More »
FirstNet announced a major expansion to its high-speed broadband communications platform for first responders this week, with additional cell sites and more than 2,000 other network enhancements tacked onto its Florida operations.
These additions will include cell sites constructed for the Band... Read More »
BioIndustrial Manufacturing and Design Ecosystem (BioMADE) has secured an $87 million Department of Defense (DoD) pact for a new Manufacturing Innovation Institute (MII).
The seven-year award to the University of Minnesota-based firm will collaborate with public and private entities to advance... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has enlisted its clinical studies network's services to assist with a COVID-19 clinical trial.
Officials said Technical Resources International, Inc. (TRI), a BARDA subsidiary, would support the clinical trial in conjunction... Read More »
The National Institute for Biological Standards and Control (NIBSC) in the United Kingdom and Q2 Solutions in the United States became the latest labs to join the Coalition for Epidemic Preparedness Innovations’ (CEPI) centralized laboratory network for COVID-19 vaccines this week.
“We are... Read More »
Last year, CARB-X awarded $127.5 million and 23 awards to developers pursuing novel ways to fight antibiotic resistant bacteria, according to its fourth annual report.
This marks the largest funding effort so far conducted by CARB-X, which coincided with several other successful milestones. For... Read More »
A cooperative effort between The University of Texas Health Science Center at Houston (UTHealth) and the Texas Department of State Health Services (DSHS) gave life to the Texas Coronavirus Antibody Response Survey (CARES) this week, to chart how many people in Texas have COVID-19... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) awarded contracts this week to ICON Government & Public Health Solutions, Pharm-Olam LLC, PRA Health Sciences, Inc., and Technical Resources International, Inc. for the development of various medical countermeasures.
Granted... Read More »
The National Institutes of Health kicked off a large, phase three clinical trial last week to chart the safety and efficacy of three modulator drugs being considered for use on patients hospitalized with COVID-19.
The three drugs to be used are Janssen Research & Development, LLC’s infliximab... Read More »
The U.S. Department of Defense (DOD) awarded a $6.98 million contract to Teel Plastics to expand the production of injection-molded and extruded swabsticks used in COVID-19 testing kits.
This award will increase production by an additional 50 million per month for each swabstick type by March... Read More »
A randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs -- like remdesivir and hydroxychloroquine, among others -- to treat COVID-19.
The results from the Solidarity Therapeutics Trial, coordinated by the World Health... Read More »
A new report by the Rand Corporation finds that Facebook users would be less likely to spread Russian propaganda if they knew it emanated from a Russian source.
Russia uses political memes to polarize Americans, particularly those at the extreme ends of the political spectrum, according to Rand... Read More »
The U.S. Army has awarded a $26 million contract modification to FLIR Systems, Inc. to support the Nuclear, Biological and Chemical Reconnaissance Vehicle Sensor Suite Upgrade (NBCRV SSU).
“Our ability to build and integrate manned and unmanned sensing solutions across a wide threat space is... Read More »
Another COVID-19 vaccine candidate shows promise for antibodies produced, at least in preclinical results released by Sanofi Pasteur and Translate Bio last week for their mRNA-based offering, MRT5500.
The candidate produced neutralizing antibodies against SARS-CoV-2 -- the virus that causes... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Beckman Coulter are joining forces to fund a multi-center clinical trial of Beckman Coulter’s Monocyte Distribution Width (MDW) hematology biomarker, a test meant to rapidly detect MIS-C.
MIS-C, or Multisystem Inflammatory... Read More »
A new Center for American Progress report details methods the United States can use to address expanding Huawei market and national security challenges and its 5G network building role.
The analysis maintains America has ignored the policies Beijing uses to make the tech company Huawei the... Read More »
The U.S. Food and Drug Administration (FDA) authorized a major medical breakthrough this week, approving Regeneron Pharmaceuticals to produce Inmazeb, the first treatment for Ebola virus infections to reach that point.
Inmazeb is a mix of three monoclonal antibodies, which work by targeting the... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) launched a study to determine whether certain approved therapies or investigational drugs show promise against COVID-19.
The ACTIV-5 Big Effect Trial is being conducted in partnership with the National Institutes of Health’s... Read More »
Sen. Susan Collins (D-ME) recently addressed the new $25 million LymeX initiative, which was announced this week in partnership between the U.S. Department of Health and Human Services and the Stephen and Alexandra Cohen Foundation.
LymeX is the largest public-private partnership to combat Lyme... Read More »
A $481 million award from the Biomedical Advanced Research and Development Authority (BARDA) and Department of Defense (DoD) this week will help Cue Health, Inc. expand the production capacity of a cartridge-based point-of-care molecular test for COVID-19.
With the fund injection, Cue aims to... Read More »
Massachusetts-based Cytiva will partner with the U.S. Departments of Health and Human Services (HHS) and Defense (DoD) to expand its manufacturing capacity for COVID-19 vaccine components and aid the federal Operation Warp Speed.
Operation Warp Speed is focused on bending U.S.-based... Read More »
The U.S. Departments of Health and Human Services (HHS) and Defense (DoD) announced greater collaboration with AstraZeneca last week, specifically aimed at the late-stage development and manufacturing of its COVID-19 treatment, AZD7442.
AZD7442 is a drug cocktail made up of two monoclonal... Read More »
At the virtual LymeMIND conference last week, the U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation announced they would partner on a $25 million endeavor known as the LymeX Innovation Accelerator.
LymeX will be the largest Lyme disease-focused... Read More »
Election interference has sounded many alarms this year, all the way to the White House and the halls of Congress. Now, the Rand Corporation is warning that a coordinated effort on Twitter to influence and provoke chaos during the upcoming presidential election is underway.
“Social media has... Read More »
Under a new partnership, the Biomedical Advanced Research and Development Authority (BARDA) will collaborate with Current Health to develop an algorithm based on a Food and Drug Administration (FDA) approved wearable monitor to predict the need for COVID-19 hospitalization.
By forecasting the... Read More »
Emergent BioSolutions Inc. is one of four companies collaborating to provide hyperimmune globulin products for a new federal clinical trial that will test the safety, tolerability and efficacy of a combination treatment regimen for COVID-19.
The regimen consists of the antiviral remdesivir plus... Read More »
U.S. Space Force personnel said the agency’s Boeing-developed Wideband Global SATCOM (WGS)-11+ communications satellite successfully completed its first major engineering design review.
“Completing this engineering design review is a key milestone and brings us one step closer to delivering... Read More »
A new test being developed by molecular diagnostics company Cepheid gained support from federal agencies this week, on the promise that it could become a one-stop-shop for diagnosing COVID-19, influenza, and RSV.
Support is coming from the Biomedical Advanced Research and Development Authority... Read More »
Biological materials management and standards organization ATCC has secured a potential 10-year, Indefinite Delivery/Indefinite Quantity (IDIQ) contract award from the Biomedical Advanced Research and Development Authority (BARDA).
The agreement, which possesses a ceiling value of $250 million,... Read More »
Over the course of three years, the Biomedical Advanced Research and Development Authority (BARDA) will pay approximately $22 million to Vaxxas to fund phase 1 clinical trials in the U.S. and Australia for a high-density microarray patch capable of administering vaccines needle-free.
This comes... Read More »
A joint effort between the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) brought $98.35 million to COVID-19 testing efforts this week, as part of six contracts awarded under the Rapid Acceleration of Diagnostics (RADx) initiative.
The... Read More »
